California Firm Trying to Buy CBN Patent

California Firm Trying to Buy CBN Patent

By: Dylan Sikes – News

Monday, April 15, 2019

The competitive field for cannabis products and all their uses just got a little tighter Monday, with the news that Irvine, Calif.-based Cannabis Science, Inc. (OTC:CBIS) is trying to close a patent deal with the government. 

The company, specializing in the development of cannabinoid-based medicines, told investors Monday that it’s negotiating to license the Company’s patent for the Compositions of Cannabinol (CBN) for a variety of ailments, most notably, sleep disorders and anxiety. 

The U.S. market for sleep disorder products alone was estimated at over $28 billion in 2017 and is expected to grow by 3.3% annually. After 2023, this market is expected to grow at an annual rate of approximately 4.7%.

The stock improved in price 12-100ths of a cent, or 3.4%, to 3.64 cents, on volume of 4.2 million shares. 

Copyright © 2019 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon

Other Penny Stock Movers

Massive Uptrend Looks Likely To Continue For This Tech Based Healthcare Stock
SRAX Lifted by Cooperative Agreement With Cint
Khiron Hails Brazilian Legalization of Cananbis
Junior Miner Pops on Review of B.C. Property

Back to Top